Email Print Share

News From the Field

NYU Tandon researcher synthesizes hybrid molecule that delivers a blow to malignant cells


April 1, 2016

This material is available primarily for archival purposes. Telephone numbers or other contact information may be out of date; please see current contact information at media contacts.

A new molecule developed at New York University (NYU) Tandon School of Engineering shows promise for treating breast cancer. The protein/polymer-gold nanoparticle composite, besides being easy to synthesize, can load up with drugs, carry them to malignant cells and unload them where they can do the most damage with the least amount of harm to the patient. It was developed by Jin Kim Montclare, an associate professor in Tandon's Department of Chemical and Biomolecular Engineering.Full Story

Source
NYU Tandon School of Engineering

The U.S. National Science Foundation propels the nation forward by advancing fundamental research in all fields of science and engineering. NSF supports research and people by providing facilities, instruments and funding to support their ingenuity and sustain the U.S. as a global leader in research and innovation. With a fiscal year 2023 budget of $9.5 billion, NSF funds reach all 50 states through grants to nearly 2,000 colleges, universities and institutions. Each year, NSF receives more than 40,000 competitive proposals and makes about 11,000 new awards. Those awards include support for cooperative research with industry, Arctic and Antarctic research and operations, and U.S. participation in international scientific efforts.

mail icon Get News Updates by Email 

Connect with us online
NSF website: nsf.gov
NSF News: nsf.gov/news
For News Media: nsf.gov/news/newsroom
Statistics: nsf.gov/statistics/
Awards database: nsf.gov/awardsearch/

Follow us on social
Twitter: twitter.com/NSF
Facebook: facebook.com/US.NSF
Instagram: instagram.com/nsfgov